UNIVERSITY OF MINNESOTA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-01

Employees: 10K

Market Cap: -

Website: http://www.umn.edu

Clinical Trials

Novel Determinants and Measures of Smokeless Tobacco Use: Study 1

Completed

Conditions: Smokeless Tobacco Use
Tobacco Dependence

First Posted Date: 2010-02-11

Last Posted Date: 2022-12-22

Lead Sponsor: University of Minnesota

Target Recruit Count: 359

Registration Number: NCT01067586

Locations: 🇺🇸
Oregon Research Institute, Eugene, Oregon, United States
🇺🇸
University of MN's Tobacco Use Research Center, Minneapolis, Minnesota, United States
🇺🇸
West Virginia University, Morgantown, West Virginia, United States

Parents As The Agent Of Change For Childhood Obesity (PAAC)

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Behavioral treatment for childhood obesity

First Posted Date: 2010-02-10

Last Posted Date: 2012-07-10

Lead Sponsor: University of Minnesota

Target Recruit Count: 80

Registration Number: NCT01066910

Locations: 🇺🇸
KDWB University Pediatrics Family Center (UMP Stand alone clinic), Minneapolis, Minnesota, United States

University of Minnesota Transplant Registry

Recruiting

Conditions: Transplant Recipient
Transplant Donation

First Posted Date: 2010-02-04

Last Posted Date: 2024-04-12

Lead Sponsor: University of Minnesota

Target Recruit Count: 10000

Registration Number: NCT01062581

Locations: 🇺🇸
University of Minnesota Transplant Information Services, Minneapolis, Minnesota, United States

Calcineurin Inhibitor Sparing After Kidney Transplantation

Phase 1

Completed

Conditions: CNI Side Effects

Interventions: Drug: Rapamune and Cellcept
Drug: Cyclosporine & Cellcept
Drug: Prograf & Cellcept
Drug: Low Dose CNI (Cyclosporine or FK) and Cellcept

First Posted Date: 2010-02-04

Last Posted Date: 2020-12-14

Lead Sponsor: University of Minnesota

Target Recruit Count: 527

Registration Number: NCT01062555

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Simvastatin Therapy for Moderate and Severe COPD

Phase 3

Terminated

Conditions: Pulmonary Disease, Chronic Obstructive

Interventions: Drug: Placebo
Drug: simvastatin

First Posted Date: 2010-02-03

Last Posted Date: 2018-01-02

Lead Sponsor: University of Minnesota

Target Recruit Count: 885

Registration Number: NCT01061671

Locations: 🇺🇸
University of Maryland Baltimore, Baltimore, Maryland, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Reliant Medical Group, Worcester, Massachusetts, United States

and more 45 locations

Effects of Genotype on CYP2C9 Drug Interactions

Completed

Conditions: Healthy

Interventions: Drug: Flurbiprofen Control - Flurbiprofen Only
Drug: Flurbiprofen Inhibition - Flurbiprofen & Fluconazole
Drug: Ketoprofen Control - Ketoprofen Only
Drug: Ketoprofen Inhibition - Ketoprofen & Fluconazole
Drug: Tolbutamide Control - Tolbutamide Only
Drug: Tolbutamide Inhibition - Tolbutamide & Fluconazole

First Posted Date: 2010-02-02

Last Posted Date: 2019-07-18

Lead Sponsor: University of Minnesota

Target Recruit Count: 23

Registration Number: NCT01061112

Locations: 🇺🇸
Clinical and Translational Science Institute, Minneapolis, Minnesota, United States

Respiratory Virus Outpatient Study (FLU 002 Plus)

Completed

Conditions: Influenza and Other Novel Respiratory Viruses

First Posted Date: 2010-01-26

Last Posted Date: 2017-08-18

Lead Sponsor: University of Minnesota

Target Recruit Count: 11719

Registration Number: NCT01056354

Locations: 🇦🇷
FUNCEI, Buenos Aires, Argentina
🇺🇸
Infectious Diseases Associates NW FL, PA, Pensacola, Florida, United States
🇺🇸
George Washington Medical Faculty Associates, Washington, D.C., District of Columbia, United States

and more 65 locations

Respiratory Virus Hospitalization Study (FLU 003 Plus)

Completed

Conditions: Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)
Influenza
Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

First Posted Date: 2010-01-26

Last Posted Date: 2024-10-21

Lead Sponsor: University of Minnesota

Target Recruit Count: 1000

Registration Number: NCT01056185

Locations: 🇵🇪
Hospital Nacional Arzobispo Loayza, Lima, Peru
🇵🇪
Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru
🇺🇸
UCSD Antiviral Research Center, San Diego, California, United States

and more 60 locations

Naltrexone and Hypoglycemia in Type 1 Diabetes

Phase 1

Completed

Conditions: Type 1 Diabetes
Hypoglycemia Unawareness

Interventions: Drug: Naltrexone
Other: Placebo

First Posted Date: 2010-01-21

Last Posted Date: 2020-02-05

Lead Sponsor: University of Minnesota

Target Recruit Count: 29

Registration Number: NCT01053078

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Innovative Interventions for Smoking Cessation

Phase 2

Completed

Conditions: Tobacco Use Disorder

Interventions: Other: VLNC Cigarette
Drug: Nicotine Patch
Other: VLNC Cigarette Plus Nicotine Patch

First Posted Date: 2010-01-15

Last Posted Date: 2019-11-18

Lead Sponsor: University of Minnesota

Target Recruit Count: 235

Registration Number: NCT01050569

Locations: 🇺🇸
University of MN's Tobacco Use Research Center, Minneapolis, Minnesota, United States
🇺🇸
University of Minnesota, Duluth, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy